COVID-19: For information related to COVID-19 (formerly referred to as “novel coronavirus"), visit

VCU Massey Cancer Center


Cellular therapeutics lab

The newest addition to VCU Massey Cancer Center's Bone Marrow Transplant (BMT) Program is the Cellular Therapeutics Lab. The new facility allows physicians to perform procedures more specifically tailored to individual cancer patients’ needs as opposed to broadly supporting intensive, high-dose chemotherapy treatments used in bone marrow transplantation.

Cellular therapeutics is where specific cellular elements of the patient’s or donor’s immune system are isolated or adapted to work as a focused therapy for cancer or immune-mediated disorders, providing new hope for patients with a myriad of diseases.

“This laboratory will allow us to take our existing adult stem cells from sources such as blood, bone marrow and umbilical cord blood and use them to their maximum potential, both in transplantation cancer therapy and immune therapy,” said John McCarty, M.D., BMT director.

The new space will allow transplant physicians to speed up their stem cell collection processes, making it safer and more efficient, and will enable them to work with twice as many cell samples at one time than in their previous space, a necessity given the growth of the transplantation program.